| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2547d83a17112d5a6a3424f30ce6660e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55544 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2016-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_645b31c183c6fa9e916b84db1053517f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8269999740bfdd086e3bc1b1b15e287f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69155b9e839a9fe660bc001a31e477e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a1d0ceebe9ad3bc896d3f65ef1c478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8e11f810ef8eccb6dc66124170def42 |
| publicationDate |
2017-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201705968-A |
| titleOfInvention |
Combination of PD-1 antagonists for the treatment of pancreatic cancer with a vaccine based on Listeria |
| abstract |
The present invention relates to combination therapies suitable for the treatment of cancer. In particular, the present invention relates to the treatment of pancreatic cancer using a combination of a planned death 1 protein (PD-1) antagonist and a live attenuated recombinant Listeria strain comprising a PEST-containing sequence. A fusion protein of a polypeptide fused to a tumor-associated antigen. |
| priorityDate |
2015-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |